Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Incyclix Bio
company
About
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
- Durham,North Carolina,United States
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $30M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- Arc Therapeutics, Inc.
- Also Known As
- ARC Therapeutics
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers. Founded by Patrick Roberts, Jay Strum, John Bisi, and Fred Eshelman in 2020 and is headquartered in Durham, North Carolina.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$36M
Incyclix Bio has raised a total of
$36M
in funding over 2 rounds. Their latest funding was raised on
Mar 31, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 31, 2022 | Series B | $30M | 3 |
Boxer Capital
|
— | Detail |
| Aug 6, 2020 | Series Unknown | $6M | 1 |
Eshelman Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Incyclix Bio is funded by 3 investors.
Boxer Capital
and Eshelman Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Boxer Capital
|
Yes | Series B |
|
Eshelman Ventures
|
— | Series B |
RA Capital Management
|
— | Series B |
Employee Profiles
Number of Employee Profiles
4
Incyclix Bio has 4 current employee profiles, including
Executive John Bisi
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
